MIRAVITLLES, Marc, Vladimir KOBLIZEK, Cristina ESQUINAS, Branislava MILENKOVIC, Adam BARCZYK, Ruzena TKACOVA, Attila SOMFAY, Kirill ZYKOV, Neven TUDORIC, Kosta KOSTOV, Zuzana ZBOŽÍNKOVÁ, Michal SVOBODA, Jurij SORLI, Alvils KRAMS and Arschang VALIPOUR. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study. RESPIRATORY MEDICINE. LONDON: W B SAUNDERS CO LTD, 2019, vol. 150, APR 2019, p. 141-148. ISSN 0954-6111. Available from: https://dx.doi.org/10.1016/j.rmed.2019.03.007.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study
Authors MIRAVITLLES, Marc (724 Spain, guarantor), Vladimir KOBLIZEK (203 Czech Republic), Cristina ESQUINAS (724 Spain), Branislava MILENKOVIC (688 Serbia), Adam BARCZYK (616 Poland), Ruzena TKACOVA (703 Slovakia), Attila SOMFAY (348 Hungary), Kirill ZYKOV (643 Russian Federation), Neven TUDORIC (191 Croatia), Kosta KOSTOV (100 Bulgaria), Zuzana ZBOŽÍNKOVÁ (203 Czech Republic, belonging to the institution), Michal SVOBODA (203 Czech Republic, belonging to the institution), Jurij SORLI (705 Slovenia), Alvils KRAMS (428 Latvia) and Arschang VALIPOUR (40 Austria).
Edition RESPIRATORY MEDICINE, LONDON, W B SAUNDERS CO LTD, 2019, 0954-6111.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.095
RIV identification code RIV/00216224:14110/19:00110576
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.rmed.2019.03.007
UT WoS 000463627700022
Keywords in English COPD; CAT; mMRC; Comorbidities; GOLD classification
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/9/2019 15:03.
Abstract
Background: The COPD Assessment Test (CAT) has been proposed to help guide therapy in chronic obstructive pulmonary disease (COPD). It is important to understand the distribution of scores in different COPD populations and their determinants. Methods: The POPE study is an international, observational cross-sectional study of COPD subjects in 11 Central and Eastern European countries aimed at characterizing COPD phenotypes. Here we report the analysis of CAT scores with the objective of identifying their determinants, evaluating symptom load and investigating the distribution of scores among the participating countries. Additionally, we investigated the discrepancies between the CAT and modified Medical Research Council (mMRC) scores when used to classify patients according to the GOLD strategy. Results: The study included 3452 patients (69.2% men, mean forced expiratory volume in 1 s (FEV1% predicted) 52.5%). The mean CAT score was 17.5 (SD = 7.8), ranging from 15.1 in Hungary to 21.2 in Bulgaria. Multiple linear regression analysis showed six variables significantly associated with CAT scores: depression, number of previous exacerbations, 6-min walking distance, FEV1(%), mMRC and country and explained 47.2% of the variance of CAT. According to either CAT or mMRC, up to 23.9% patients would be classified in different GOLD groups. Conclusions: The CAT score may be predicted by factors related to COPD severity, depression and exercise capacity, with significant differences in the distribution of CAT scores in different countries. According to our results CAT > 10 is not equivalent to mMRC > 2 for assessing symptom burden.
PrintDisplayed: 24/7/2024 12:22